Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Denali Therapeutics Announces Pricing Of Public Offering Of Common Stock is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics ... today announced the pricing of an underwritten public offering of 4,440,851 shares of its common stock at a public offering price of $46.50 ... Read More
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics ... today announced the pricing of its underwritten public offering of 6,471,000 shares of its common stock at a price to the ... Read More
Contineum Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Contineum Therapeutics ... indications with high unmet need, today announced the pricing of its initial public offering of 6,875,000 shares of its Class A ... Read More
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics ... today announced the pricing of an underwritten public offering of 16,666,667 shares of its common stock at a public ... Read More
Bowman Announces Pricing of Public Offering of Common Stock
Bowman and the selling stockholders have granted the underwriters an option to purchase up to an additional 220,588 shares of common stock at the public offering price, less underwriting discounts ... Read More
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
PURCHASE, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics ... disorders, today announced that it has priced an underwritten public offering of 6,571,428 shares of its common stock at ... Read More
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics ... today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Read More
Nurix Therapeutics Announces Pricing Of Upsized $175.0 Million Public Offering
Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten public offering of 10,166,667 shares of its common stock at a price to the public of $15.00 per share. Read More
Jasper Therapeutics Announces Offering Pricing Details
Jasper Therapeutics (JSPR) has released an update. The Company has publicly announced the pricing details of its Offering on February 6, 2024, through a press release. This information is crucial ... Read More
Contineum Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Contineum Therapeutics ... today announced the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus